GE HealthCare to Acquire SOFIE Biosciences for $945M – Bolstering PET Radiopharmaceutical Manufacturing and Securing Phase III FAPI‑74 Asset
GE HealthCare Technologies Inc. (NASDAQ: GEHC) announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.‑based contract manufacturing organization (CMO) for PET radiopharmaceuticals, from Trilantic North America for a…
Empowering Chinese Pharma’s Global Expansion
Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
